Cargando…
Low 25(OH)D Level Is Associated with Severe Course and Poor Prognosis in COVID-19
We evaluated associations between serum 25-hydroxyvitamin D [25(OH)D] level and severity of new coronavirus infection (COVID-19) in hospitalized patients. We assessed serum 25(OH)D level in 133 patients aged 21–93 years. Twenty-five (19%) patients had severe disease, 108 patients (81%) had moderate...
Autores principales: | Karonova, Tatiana L., Andreeva, Alena T., Golovatuk, Ksenia A., Bykova, Ekaterina S., Simanenkova, Anna V., Vashukova, Maria A., Grant, William B., Shlyakhto, Evgeny V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468115/ https://www.ncbi.nlm.nih.gov/pubmed/34578898 http://dx.doi.org/10.3390/nu13093021 |
Ejemplares similares
-
Vitamin D Intake May Reduce SARS-CoV-2 Infection Morbidity in Health Care Workers
por: Karonova, Tatiana L., et al.
Publicado: (2022) -
Vitamin D Status and Immune Response in Hospitalized Patients with Moderate and Severe COVID-19
por: Karonova, Tatiana L., et al.
Publicado: (2022) -
Effect of Cholecalciferol Supplementation on the Clinical Features and Inflammatory Markers in Hospitalized COVID-19 Patients: A Randomized, Open-Label, Single-Center Study
por: Karonova, Tatiana L., et al.
Publicado: (2022) -
Predictors of Effectiveness of Glucagon-Like Peptide-1 Receptor Agonist Therapy in Patients with Type 2 Diabetes and Obesity
por: Babenko, Alina Yu., et al.
Publicado: (2019) -
Cytokine Storm Signature in Patients with Moderate and Severe COVID-19
por: Kalinina, Olga, et al.
Publicado: (2022)